George C. Tsokos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
George C. Tsokos has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Madhusoodana P. Nambiar
Department of Cellular Injury, Walter Reed Army Institute of Research , Silver Spring, MD 20910
7 shared publicationsCarolyn U. Fisher
Department of Cellular Injury, Walter Reed Army Institute of Research , Silver Spring, MD 20910
6 shared publicationsEdith J. Enyedy
Department of Cellular Injury, Walter Reed Army Institute of Research, Building 503, Robert Grant Avenue, Silver Spring, MD 20910-7500, USA
5 shared publicationsVishal G. Warke
Department of Cellular Injury, Walter Reed Army Institute of Research, Building 503, Robert Grant Avenue, Silver Spring, MD 20910-7500, USA
5 shared publicationsSandeep Krishnan
Department of Cellular Injury, Walter Reed Army Institute of Research , Silver Spring, MD 20910
3 shared publications- Stamatis-Nick C. Liossis
Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, GR 26504 Patras, Greece
3 shared publications
Latest Publications
- Open Access
- 1 December 2006
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 177 (11) , 8248-8257
Stability and Translation of TCR ζ mRNA Are Regulated by the Adenosine-Uridine-Rich Elements in Splice-Deleted 3′ Untranslated Region of ζ-Chain
Systemic lupus erythematosus (SLE) T cells display reduced expression of TCR ζ protein. Recently, we reported that in SLE T cells, the residual TCR ζ protein is predominantly derived from an alternatively spliced form that undergoes splice deletion of 562 nt (from 672 to 1233 bases) within the 3′ untranslated region (UTR) of TCR ζ mRNA. The stability and translation of the alternatively spliced form of TCR ζ mRNA are low compared with that of the wild-type TCR ζ mRNA. We report that two adenosine-uridine-rich sequence elements (AREs), defined by the splice-deleted 3′ UTR region, but not an ARE located upstream are responsible for securing TCR ζ mRNA stability and translation. The stabilizing effect of the splice-deleted region-defined AREs extended to the luciferase mRNA and was not cell type-specific. The findings demonstrate distinct sequences within the splice-deleted region 672 to 1233 of the 3′ UTR, which regulate the transcription, mRNA stability, and translation of TCR ζ mRNA. The absence of these sequences represents a molecular mechanism that contributes to altered TCR ζ-chain expression in lupus.
- 1 December 2006
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 177 (11) , 8248-8257
Open AccessStability and Translation of TCR ζ mRNA Are Regulated by the Adenosine-Uridine-Rich Elements in Splice-Deleted 3′ Untranslated Region of ζ-Chain
Systemic lupus erythematosus (SLE) T cells display reduced expression of TCR ζ protein. Recently, we reported that in SLE T cells, the residual TCR ζ protein is predominantly derived from an alternatively spliced form that undergoes splice deletion of 562 nt (from 672 to 1233 bases) within the 3′ untranslated region (UTR) of TCR ζ mRNA. The stability and translation of the alternatively spliced form of TCR ζ mRNA are low compared with that of the wild-type TCR ζ mRNA. We report that two adenosine-uridine-rich sequence elements (AREs), defined by the splice-deleted 3′ UTR region, but not an ARE located upstream are responsible for securing TCR ζ mRNA stability and translation. The stabilizing effect of the splice-deleted region-defined AREs extended to the luciferase mRNA and was not cell type-specific. The findings demonstrate distinct sequences within the splice-deleted region 672 to 1233 of the 3′ UTR, which regulate the transcription, mRNA stability, and translation of TCR ζ mRNA. The absence of these sequences represents a molecular mechanism that contributes to altered TCR ζ-chain expression in lupus.
- 28 February 2006
- Published by Elsevier in Autoimmunity Reviews
- Vol. 5 (2) , 85
Clinical Immunology Society spring school on Systemic Autoimmune Diseases, Santa Fe, New Mexico, USA, March 2–6, 2005
- 28 February 2006
- Published by Elsevier in Autoimmunity Reviews
- Vol. 5 (2) , 85
Clinical Immunology Society spring school on Systemic Autoimmune Diseases, Santa Fe, New Mexico, USA, March 2–6, 2005
- Open Access
- 1 February 2006
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 176 (3) , 1295-1296
In the Beginning Was Sm
- 1 February 2006
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 176 (3) , 1295-1296
Open AccessIn the Beginning Was Sm
- Open Access
- 4 November 2004
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (11) , 3404-3407
Exploring complement activation to develop biomarkers for systemic lupus erythematosus
- 4 November 2004
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (11) , 3404-3407
Open AccessExploring complement activation to develop biomarkers for systemic lupus erythematosus
- 1 November 2003
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 112 (9) , 1315-1317
The TRAIL to arthritis
Antigen-specific lymphocytes are involved in synovial proliferation within inflamed joints. Activated lymphocytes and synoviocytes from patients with rheumatoid arthritis express receptors that can bind TNF-related apoptosis-inducing ligand (TRAIL). A new study demonstrates that DCs pulsed with collagen and transduced with an adenovirus-based vector able to express TRAIL limit the incidence of arthritis in a model of collagen-induced arthritis and joint inflammation. These results suggest that gene-modified cell therapy represents a therapeutic option for systemic rheumatic diseases.
- 1 November 2003
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 112 (9) , 1315-1317
The TRAIL to arthritis
Antigen-specific lymphocytes are involved in synovial proliferation within inflamed joints. Activated lymphocytes and synoviocytes from patients with rheumatoid arthritis express receptors that can bind TNF-related apoptosis-inducing ligand (TRAIL). A new study demonstrates that DCs pulsed with collagen and transduced with an adenovirus-based vector able to express TRAIL limit the incidence of arthritis in a model of collagen-induced arthritis and joint inflammation. These results suggest that gene-modified cell therapy represents a therapeutic option for systemic rheumatic diseases.
- 1 September 2003
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 15 (5) , 542-547
T cell abnormalities in human and mouse lupus: intrinsic and extrinsic
The purpose of this review is to discuss recent developments in the biology and biochemistry of the T cells in mice and humans with systemic lupus erythematosus. T cells that recognize self-antigens are present in systemic lupus erythematosus and normal organisms. It is obvious, though, that an autoimmune environment should be present to disrupt anergy and instigate a response that might cause disease. The environment that lifts anergy is defined by distinct molecular aberrations that include rewiring of the T cells. Aberrant transcription of genes that encode proteins involved in autoimmunity can be traced to abnormal expression and activation of transcription factors and promoter methylation intensity. Only certain components of the autoimmune response can be linked to pathologic changes in the target organ that might be dictated by additional local factors. The works reviewed imply that self-peptides might be considered to reestablish lost tolerance, whereas correction of the aberrant biochemistry might normalize T cell function and limit disease.
- 1 September 2003
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 15 (5) , 542-547
T cell abnormalities in human and mouse lupus: intrinsic and extrinsic
The purpose of this review is to discuss recent developments in the biology and biochemistry of the T cells in mice and humans with systemic lupus erythematosus. T cells that recognize self-antigens are present in systemic lupus erythematosus and normal organisms. It is obvious, though, that an autoimmune environment should be present to disrupt anergy and instigate a response that might cause disease. The environment that lifts anergy is defined by distinct molecular aberrations that include rewiring of the T cells. Aberrant transcription of genes that encode proteins involved in autoimmunity can be traced to abnormal expression and activation of transcription factors and promoter methylation intensity. Only certain components of the autoimmune response can be linked to pathologic changes in the target organ that might be dictated by additional local factors. The works reviewed imply that self-peptides might be considered to reestablish lost tolerance, whereas correction of the aberrant biochemistry might normalize T cell function and limit disease.
- 1 January 2003
- Published by S. Karger AG
- Vol. 7, 149-164
Autoimmunity, Complement Activation, Tissue Injury and Reciprocal Effects
Proteins of the complement system limit the expression of systemic autoimmunity by raising the threshold for negative selection and, in their absence, autoreactive lymphocytes seem to enter the periphery. On the other hand, complement activation in the course of systemic autoimmunity leads to tissue injury in a number of ways including direct lysis of cells, modification of cell function and by contributing to the formation of immune complexes. Excessive complement activation as a result of a regulator component deficiency leads to tissue injury that mimics that seen in autoimmune disease. Complement activation occurs during tissue injury and contributes in a major way to the expression of pathology. It appears that natural antibodies represent an early culprit in tissue injury following ischemia/reperfusion injury. Natural antibodies and probably autoantibodies present in sera of patients with systemic autoimmune disease bind to tissues already exposed to a damaging insult, activate complement and produce pathology.
- 1 January 2003
- Published by S. Karger AG
- Vol. 7, 149-164
Autoimmunity, Complement Activation, Tissue Injury and Reciprocal Effects
Proteins of the complement system limit the expression of systemic autoimmunity by raising the threshold for negative selection and, in their absence, autoreactive lymphocytes seem to enter the periphery. On the other hand, complement activation in the course of systemic autoimmunity leads to tissue injury in a number of ways including direct lysis of cells, modification of cell function and by contributing to the formation of immune complexes. Excessive complement activation as a result of a regulator component deficiency leads to tissue injury that mimics that seen in autoimmune disease. Complement activation occurs during tissue injury and contributes in a major way to the expression of pathology. It appears that natural antibodies represent an early culprit in tissue injury following ischemia/reperfusion injury. Natural antibodies and probably autoantibodies present in sera of patients with systemic autoimmune disease bind to tissues already exposed to a damaging insult, activate complement and produce pathology.
- 1 May 2002
- Published by Elsevier in Clinical Immunology
- Vol. 103 (2) , 145-153
Direct Transfer of p65 into T Lymphocytes from Systemic Lupus Erythematosus Patients Leads to Increased Levels of Interleukin-2 Promoter Activity
- 1 May 2002
- Published by Elsevier in Clinical Immunology
- Vol. 103 (2) , 145-153
Direct Transfer of p65 into T Lymphocytes from Systemic Lupus Erythematosus Patients Leads to Increased Levels of Interleukin-2 Promoter Activity
- 28 February 2002
- Published by Elsevier in Cellular Immunology
- Vol. 215 (2) , 151-161
Oxidative stress is involved in the heat stress-induced downregulation of TCR ζ chain expression and TCR/CD3-mediated [Ca2+]i response in human T-lymphocytes
- 28 February 2002
- Published by Elsevier in Cellular Immunology
- Vol. 215 (2) , 151-161
Oxidative stress is involved in the heat stress-induced downregulation of TCR ζ chain expression and TCR/CD3-mediated [Ca2+]i response in human T-lymphocytes
- Open Access
- 18 January 2002
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (1) , 163-174
Abnormal expression of various molecular forms and distribution of T cell receptor ? chain in patients with systemic lupus erythematosus
Objective T cells from the majority of patients with systemic lupus erythematosus (SLE) display antigen receptor‐mediated signaling aberrations associated with defective T cell receptor (TCR) ζ chain expression. The TCR ζ chain, a critical signaling molecule, exists in multiple molecular forms and membrane fractions with distinct functions in antigen‐mediated signaling processes. This study was undertaken to investigate the complete spectrum of expression of the different forms and distribution of the TCR ζ chain in SLE T cells. Methods T cells were isolated from 48 SLE patients and 21 healthy subjects. The expression of various forms of the TCR ζ chain was investigated by immunoblotting with specific antibodies. The lipid raft‐associated form of the ζ chain was determined by quantitating the solubilized ζ chain after disruption of the lipid rafts by cholesterol depletion using methyl‐β‐cyclodextrin. The distribution of the ζ chain was investigated by fluorescence microscopy. Results The phosphorylated 21‐ and 23‐kd forms and the detergent‐insoluble membrane‐associated form of the TCR ζ chain and alternatively spliced ζ chain were significantly decreased in SLE T cells. In contrast, major ubiquitinated forms of the ζ chain were increased in these cells. We also identified up‐regulation of a novel 14‐kd form of the ζ chain in SLE T cells. Resting SLE T cell membranes had an increased percentage of the residual membrane‐bound ζ chain in the lipid rafts. Fluorescence microscopy findings indicated that the residual ζ chain is more clustered on the cell membranes of SLE T cells. Conclusion These results suggest that, in addition to the 16‐kd form, expression of other molecular forms and fractions of the TCR ζ chain as well as its membrane distribution are abnormal in SLE T cells. Increased lipid raft association and surface clustering of the ζ chain may explain the molecular mechanisms underlying the signaling abnormalities in these cells.
- 18 January 2002
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (1) , 163-174
Open AccessAbnormal expression of various molecular forms and distribution of T cell receptor ? chain in patients with systemic lupus erythematosus
Objective T cells from the majority of patients with systemic lupus erythematosus (SLE) display antigen receptor‐mediated signaling aberrations associated with defective T cell receptor (TCR) ζ chain expression. The TCR ζ chain, a critical signaling molecule, exists in multiple molecular forms and membrane fractions with distinct functions in antigen‐mediated signaling processes. This study was undertaken to investigate the complete spectrum of expression of the different forms and distribution of the TCR ζ chain in SLE T cells. Methods T cells were isolated from 48 SLE patients and 21 healthy subjects. The expression of various forms of the TCR ζ chain was investigated by immunoblotting with specific antibodies. The lipid raft‐associated form of the ζ chain was determined by quantitating the solubilized ζ chain after disruption of the lipid rafts by cholesterol depletion using methyl‐β‐cyclodextrin. The distribution of the ζ chain was investigated by fluorescence microscopy. Results The phosphorylated 21‐ and 23‐kd forms and the detergent‐insoluble membrane‐associated form of the TCR ζ chain and alternatively spliced ζ chain were significantly decreased in SLE T cells. In contrast, major ubiquitinated forms of the ζ chain were increased in these cells. We also identified up‐regulation of a novel 14‐kd form of the ζ chain in SLE T cells. Resting SLE T cell membranes had an increased percentage of the residual membrane‐bound ζ chain in the lipid rafts. Fluorescence microscopy findings indicated that the residual ζ chain is more clustered on the cell membranes of SLE T cells. Conclusion These results suggest that, in addition to the 16‐kd form, expression of other molecular forms and fractions of the TCR ζ chain as well as its membrane distribution are abnormal in SLE T cells. Increased lipid raft association and surface clustering of the ζ chain may explain the molecular mechanisms underlying the signaling abnormalities in these cells.